Patents by Inventor Anthony FRANK

Anthony FRANK has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200392491
    Abstract: The present invention relates to compositions comprising oligonucleotides, specifically SMAD7 antisense oligonucleotides, and methods for preparing the same.
    Type: Application
    Filed: July 26, 2018
    Publication date: December 17, 2020
    Inventors: Anthony Frank, Kevin Klopfer, Donald Joseph Gallagher, Jr., Laleh Jafarpour
  • Patent number: 10604510
    Abstract: Provided herein are compositions including the crystalline forms of (1E, 4E)-2-amino-N,N-dipropyl-8-(4-(pyrrolidine-1-carbonyl)phenyl)-3H-benzo[b]azepine-4-carboxamide (“Compound A”), methods of making the crystalline forms, and methods of using the crystalline forms for the treatment of diseases, including, for example, cancer.
    Type: Grant
    Filed: September 13, 2019
    Date of Patent: March 31, 2020
    Assignee: Celgene Corporation
    Inventors: Hon-Wah Man, Timothy D. Fitzpatrick, Anthony Frank, Ying Li, Xiaoling Lu, Marie G. Beauchamps, Antonio C. Ferretti
  • Publication number: 20200002316
    Abstract: Provided herein are compositions including the crystalline forms of (1E, 4E)-2-amino-N,N-dipropyl-8-(4-(pyrrolidine-1-carbonyl)phenyl)-3H-benzo[b]azepine-4-carboxamide (“Compound A”), methods of making the crystalline forms, and methods of using the crystalline forms for the treatment of diseases, including, for example, cancer.
    Type: Application
    Filed: September 13, 2019
    Publication date: January 2, 2020
    Inventors: Hon-Wah MAN, Timothy D. FITZPATRICK, Anthony FRANK, Ying LI, Xiaoling LU, Marie G. BEAUCHAMPS, Antonio C. FERRETTI
  • Publication number: 20190100512
    Abstract: Provided herein are compositions including the crystalline forms of (1E, 4E)-2-amino-N,N-dipropyl-8-(4-(pyrrolidine-1-carbonyl)phenyl)-3H-benzo[b] azepine-4-carboxamide (“Compound A”), methods of making the crystalline forms, and methods of using the crystalline forms for the treatment of diseases, including, for example, cancer.
    Type: Application
    Filed: December 15, 2015
    Publication date: April 4, 2019
    Applicant: Celgene Corporation
    Inventors: Hon-Wah MAN, Timothy D. FITZPATRICK, Anthony FRANK, Ying LI, Xiaoling LU, Marie G. BEAUCHAMPS, Antonio C. FERRETTI